← Leaderboards
Zhen Zhang
Johns Hopkins University
$10,302,020
Attributed
$24,205,067
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,299,565 · 7
By mechanism
U24$15,988,224 · 2
U2C$6,024,953 · 3
U01$5,286,388 · 2
Top collaborators
- Daniel W Chan14 shared
- Hui Zhang14 shared
- Ie-Ming Shih10 shared
- Randall Brand3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Anirban Maitra$50,247,714
- Daniel W Chan$17,758,540
- Michael G. Goggins$19,822,981
- Nancy E Davidson$32,860,580
- Gloria M. Petersen$29,119,396
Others in their field
Top investigators on “Multidisciplinary”
- Lawrence Corey · Fred Hutchinson Cancer Center$298,997,339
- David Heimbrook · Leidos Biomedical Research, Inc.$251,484,793
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Gregory H Reaman · National Childhood Cancer Foundation$201,951,987
- Judith S. Currier · University Of California Los Angeles$188,628,043
- Barton F Haynes · Duke University$186,871,361
Research focus
MultidisciplinaryResearch PersonnelSpecimenSamplingMalignant NeoplasmsBaseSuccessBiological MarkersScreening For Ovarian CancerFutureBioinformaticsTumorBiometryProteomicsMass Spectrum AnalysisAssay DevelopmentMolecularDesignEarly Detection Research NetworkTissuesPathway InteractionsClinical ChemistryResourcesTechnology
Grant awards (29)
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$809,563
U01 · FY2025 · CA
Administrative Core$598,864
U2C · FY2025 · CA · contact PI
A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach$598,864
U2C · FY2025 · CA · contact PI
Administrative Core$892,664
U2C · FY2024 · CA · contact PI
A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach$892,664
U2C · FY2024 · CA · contact PI
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$769,085
U01 · FY2024 · CA
A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach$923,097
U2C · FY2023 · CA · contact PI
Administrative Core$923,097
U2C · FY2023 · CA · contact PI
Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions$825,499
U01 · FY2023 · CA
A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach$679,873
U2C · FY2022 · CA · contact PI
Biomarker Developmental Laboratory$474,966
U2C · FY2022 · CA · contact PI
Administrative Core$40,864
U2C · FY2022 · CA · contact PI
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer$309,067
U01 · FY2021 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,061,100
U24 · FY2020 · CA
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer$534,604
U01 · FY2020 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,029,264
U24 · FY2019 · CA
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer$692,310
U01 · FY2019 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,061,100
U24 · FY2018 · CA
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer$441,524
U01 · FY2018 · CA · contact PI
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,059,750
U24 · FY2017 · CA
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer$441,524
U01 · FY2017 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cance Research$1,307,657
U24 · FY2016 · CA
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic Targets$1,056,780
U24 · FY2016 · CA
Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer$463,212
U01 · FY2016 · CA · contact PI
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,859,557
U24 · FY2015 · CA
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,890,981
U24 · FY2014 · CA
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,824,239
U24 · FY2013 · CA
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,875,068
U24 · FY2012 · CA
Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers$1,962,728
U24 · FY2011 · CA